SEC 13F Intelligence

Candriam S.c.a. / VRTX

Candriam S.c.a.’s Vertex Pharmaceuticals Inc Position

Does Candriam S.c.a. own Vertex Pharmaceuticals Inc (VRTX)? Yes — 225.3K shares worth $102M (+0.51% of its 13F portfolio) as of Q1 2026.

Position Value
$102M
Q1 2026
Shares
225.3K
% of Portfolio
+0.51%
Quarters Held
30
currently held

Position History VRTX

Reported value by quarter
Q4 ’18: $105MQ4 ’18Q1 ’19: $122MQ2 ’19: $172MQ3 ’19: $158,000Q4 ’19: $159MQ4 ’19Q1 ’20: $155MQ2 ’20: $159MQ3 ’20: $152MQ4 ’20: $184MQ4 ’20Q1 ’21: $177MQ2 ’21: $163MQ3 ’21: $108MQ4 ’21: $142MQ4 ’21Q1 ’22: $124MQ2 ’22: $132MQ3 ’22: $140MQ4 ’22: $135MQ4 ’22Q1 ’23: $113MQ2 ’23: $140MQ3 ’23: $134MQ4 ’23: $139MQ4 ’23Q1 ’24: $162MQ2 ’24: $154MQ3 ’24: $145MQ4 ’24: $104MQ4 ’24Q1 ’25: $96MQ2 ’25: $79MQ3 ’25: $68MQ4 ’25: $102MQ4 ’25Q1 ’26: $102Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026225.3K$102M+0.51%
Q4 2025225.3K$102M+0.51%
Q3 2025174.6K$68M+0.36%
Q2 2025176.4K$79M+0.45%
Q1 2025198.3K$96M+0.60%
Q4 2024258.6K$104M+0.60%
Q3 2024311.3K$145M+0.83%
Q2 2024328.3K$154M+0.93%
Q1 2024388.6K$162M+1.04%
Q4 2023342.1K$139M+0.96%
Q3 2023384.3K$134M+0.95%
Q2 2023396.6K$140M+1.01%
Q1 2023390.9K$113M+0.79%
Q4 2022469.1K$135M+0.91%
Q3 2022484.5K$140M+0.99%
Q2 2022467.9K$132M+1.09%
Q1 2022474.3K$124M+0.84%
Q4 2021644.6K$142M+0.90%
Q3 2021592.8K$108M+0.73%
Q2 2021807.9K$163M+1.11%
Q1 2021779.5K$177M+1.47%
Q4 2020779.5K$184M+1.46%
Q3 2020558.1K$152M+1.43%
Q2 2020546.2K$159M+1.67%
Q1 2020725.4K$155M+1.72%
Q4 2019725.4K$159M+1.70%
Q3 2019931.0K$158,000+1.99%
Q2 2019940.5K$172M+2.14%
Q1 2019661.5K$122M+1.56%
Q4 2018635.4K$105M+1.62%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Candriam S.c.a.’s full portfolio or all institutional holders of VRTX.